Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

EGX:AXPH Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	494.04	391.17	216.68	126.43	117.42	117
Depreciation & Amortization	66.18	43.22	-	-	23.18	-
Other Operating Activities	-221.41	-98.4	-27.06	-35.09	52.14	-17.57
Operating Cash Flow	338.81	335.99	189.62	91.34	192.75	99.42
Operating Cash Flow Growth	53.96%	77.19%	107.60%	-52.61%	93.87%	-28.88%
Capital Expenditures	-46.71	-29.72	-62.22	-84.25	-31.85	-119.99
Sale of Property, Plant & Equipment	-	-	0.56	1.03	-	0.4
Other Investing Activities	0.24	2.98	13.33	5.38	5.25	5.97
Investing Cash Flow	-46.47	-26.74	-48.33	-77.84	-26.6	-113.62
Common Dividends Paid	-285.06	-173.68	-81.97	-76.94	-64.52	-100.29
Financing Cash Flow	-285.06	-173.68	-81.97	-76.94	-64.52	-100.29
Net Cash Flow	7.29	135.57	59.33	-63.44	101.63	-114.49
Free Cash Flow	292.1	306.27	127.41	7.09	160.9	-20.57
Free Cash Flow Growth	81.73%	140.39%	1696.05%	-95.59%	-	-
Free Cash Flow Margin	9.67%	11.13%	7.21%	0.48%	14.63%	-1.86%
Free Cash Flow Per Share	58.42	61.25	25.48	1.42	32.18	-4.11
Cash Income Tax Paid	154.17	91.62	51.65	46.02	49.3	62.87
Levered Free Cash Flow	279.59	249.05	85.19	-44.18	155.37	-46.87
Unlevered Free Cash Flow	279.59	249.05	85.19	-44.18	155.37	-46.87

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.